
	Beauty		Grooming		Health Care		Fabric & Home Care		Baby, Feminine & Family Care		TOTAL
BALANCE AT JUNE 30, 2023 - NET (1)	$	13,888	$	12,703	$	7,718	$	1,821	$	4,529	$	40,659
Acquisitions and divestitures	(61)		—		—		—		—		(61)
Translation and other	(104)		(71)		(80)		(10)		(30)		(295)
BALANCE AT JUNE 30, 2024 - NET (1)	13,723		12,633		7,638		1,810		4,499		40,303
Acquisitions and divestitures	—		—		—		—		—		—
Translation and other	507		360		303		38		141		1,348
BALANCE AT JUNE 30, 2025 - NET (1)	$	14,229	$	12,993	$	7,941	$	1,848	$	4,640	$	41,650

Goodwill and indefinite-lived intangibles are tested for impairment at least annually by comparing the estimated fair values of our reporting units and indefinite-lived intangible assets to their respective carrying values. We use the income method to estimate the fair value of these assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. When appropriate, the market approach, which leverages comparable company revenue and earnings multiples, is weighted with the income approach to estimate fair value. Significant estimates and assumptions inherent in the valuations reflect a consideration of other marketplace participants and include the amount and timing of future cash flows (including expected growth rates and profitability). Significant judgment by management is required to estimate the impact of macroeconomic and other factors on future cash flows. Estimates utilized in the projected cash flows include consideration of macroeconomic conditions, overall category growth rates, competitive activities, cost containment and margin expansion, Company business plans, the underlying product or technology life cycles, economic barriers to entry, a brand's relative market position and the discount rate applied to the cash flows. Unanticipated market or macroeconomic events and circumstances may occur, which could affect the accuracy or validity of the estimates and assumptions.

We believe the estimates and assumptions utilized in our impairment testing are reasonable and are comparable to those that would be used by other marketplace participants. However, actual events and results could differ substantially from those used in our valuations. To the extent such factors result in a failure to achieve the level of projected cash flows initially used to estimate fair value for purposes of establishing or subsequently impairing the carrying amount of goodwill and related intangible assets, we may need to record additional non-cash impairment charges in the future.

As previously disclosed, we recorded a non-cash impairment charge of $1.3 billion ($1.0 billion after tax) on the Gillette indefinite-lived intangible asset during the fiscal year ended June 30, 2024. The impairment charge arose due to a higher discount rate, weakening of several currencies relative to the U.S. dollar and the impact of a new restructuring program focused primarily in certain Enterprise Markets, including Argentina and Nigeria. Following the impairment charge, the carrying value of the Gillette indefinite-lived intangible asset was equivalent to the estimated fair value as of December 31, 2023.


	2025				2024
As of June 30	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
INTANGIBLE ASSETS WITH DETERMINABLE LIVES
Brands	$	4,449	$	(3,019)	$	4,318	$	(2,725)
Patents and technology	2,803		(2,722)		2,794		(2,683)
Customer relationships	1,879		(1,236)		1,834		(1,121)
Other	73		(31)		72		(29)
TOTAL	$	9,204	$	(7,008)	$	9,019	$	(6,558)

INTANGIBLE ASSETS WITH INDEFINITE LIVES
Brands	19,714		—		19,587		—

TOTAL INTANGIBLE ASSETS	$	28,918	$	(7,008)	$	28,605	$	(6,558)